Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 00:40:35 - browse：4642

Closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. — A brain affected by Alzheimer's disease, at the Museum of Neuroanatomy at the University at Buffalo. David Duprey/AP

Investigators on Wednesday released the first detailed case report about a patient who died after receiving lecanemab, providing a new glimpse into safety concerns surrounding the closely watched experimental Alzheimer’s drug.

An unpublished version of the report was previously written about by Science in November, one of three deaths from the lecanemab trials revealed by Science and STAT. But the published version, in the New England Journal of Medicine, will allow doctors to evaluate the case as they consider whether and how to use a treatment that could be approved by the FDA as soon as this week.

This “will have greater impact on clinicians because it is peer-reviewed and published in the New England Journal,” said Lon Schneider, an Alzheimer’s expert at University of Southern California, who was not affiliated with the work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

WSS

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

NIH documents show early flaws of $1.6 billion long Covid program

BMI, flaws aside, is found to be useful estimate of body fat in youth

Congress extends some pandemic preparedness programs

What we owe ALS patients — and why one company fell short

Change Healthcare can notify patients about the breach, HHS says

hotspot

Wikipedia

explore

Dobbs anniversary: the lost opportunity of abortion as health care

The Karikó problem: Lessons for funding basic research

DIEP, the 'gold standard' of breast reconstruction, is under threat

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What we owe ALS patients — and why one company fell short

Malaria cases in Florida and Texas: Here’s what you need to know

With Roe v Wade overturned, abortion providers work to adapt

Supreme Court strikes down use of affirmative action

NIH documents show early flaws of $1.6 billion long Covid program

knowledge

See how much Covid

BMI, flaws aside, is found to be useful estimate of body fat in youth

Lawsuit highlights wrinkle for disputes over surprise medical bills

ASCO: AstraZeneca says CAR

The stability of $0 premiums in Medicare Advantage

Health insurers' Q3 question: how much care are people getting?

entertainment

focus

focus

leisure time